These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36979836)

  • 21. Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System.
    Ernzen K; Trask AJ; Peeples ME; Garg V; Zhao MT
    Stem Cell Rev Rep; 2021 Dec; 17(6):2107-2119. PubMed ID: 34365591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery.
    Giani AM; Chen S
    Stem Cell Res; 2021 May; 53():102207. PubMed ID: 33677394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2.
    Rangu R; Wander PL; Barrow BM; Zraika S
    J Mol Endocrinol; 2022 Jun; 69(2):R63-R79. PubMed ID: 35521990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system.
    Ostermann PN; Schaal H
    Rev Med Virol; 2023 Mar; 33(2):e2430. PubMed ID: 36790825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and Diabetes.
    Singh AK; Khunti K
    Annu Rev Med; 2022 Jan; 73():129-147. PubMed ID: 34379444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication.
    Lui VC; Hui KP; Babu RO; Yue H; Chung PH; Tam PK; Chan MC; Wong KK
    Sci Rep; 2022 Mar; 12(1):5375. PubMed ID: 35354880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models.
    Egilmezer E; Rawlinson WD
    Rev Med Virol; 2021 Nov; 31(6):e2227. PubMed ID: 33763936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Infection Causes Hyperglycemia in Cats.
    Zhang Y; Gao J; Huang K; Zhao Y; Hui X; Wang T; Hu C; Sun X; Yang Y; Wu C; Chen X; Zou Z; Zhao LZ; Jin M
    J Infect Dis; 2022 Nov; 226(9):1568-1576. PubMed ID: 35639863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New onset diabetes, type 1 diabetes and COVID-19.
    Boddu SK; Aurangabadkar G; Kuchay MS
    Diabetes Metab Syndr; 2020; 14(6):2211-2217. PubMed ID: 33395782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients.
    Ji N; Zhang M; Ren L; Wang Y; Hu B; Xiang J; Gong Y; Wu C; Qu G; Ding W; Yin Z; Li S; Wang Z; Zhou L; Chen X; Ma Y; Tang J; Liu Y; Liu L; Huang M
    Emerg Microbes Infect; 2022 Dec; 11(1):1115-1125. PubMed ID: 35343389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
    Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
    Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models.
    Basu A; Pamreddy A; Singh P; Sharma K
    J Mol Biol; 2022 Feb; 434(3):167213. PubMed ID: 34437890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defense of COVID-19 by Human Organoids.
    Lv T; Meng F; Yu M; Huang H; Lin X; Zhao B
    Phenomics; 2021; 1(3):113-128. PubMed ID: 35233559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of SARS-CoV-2 receptor "ACE2" in human pancreatic β cells: to be or not to be!
    El-Huneidi W; Hamad M; Taneera J
    Islets; 2021 Sep; 13(5-6):106-114. PubMed ID: 34304698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
    Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
    Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of Human Pluripotent Stem Cell-Derived Skin Organoids Enabled Pathophysiological Model of SARS-CoV-2 Infection.
    Ma J; Liu J; Gao D; Li X; Zhang Q; Lv L; Wang Y; Li J; Zhu Y; Wu Z; Hu H; Li Y; Ma L; Liu Q; Hu Z; Zhang S; Zhou Y; Wang M; Leng L
    Adv Sci (Weinh); 2022 Mar; 9(7):e2104192. PubMed ID: 34971128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection of bat and human intestinal organoids by SARS-CoV-2.
    Zhou J; Li C; Liu X; Chiu MC; Zhao X; Wang D; Wei Y; Lee A; Zhang AJ; Chu H; Cai JP; Yip CC; Chan IH; Wong KK; Tsang OT; Chan KH; Chan JF; To KK; Chen H; Yuen KY
    Nat Med; 2020 Jul; 26(7):1077-1083. PubMed ID: 32405028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data.
    Venkatesh N; Astbury N; Thomas MC; Rosado CJ; Pappas E; Krishnamurthy B; MacIsaac RJ; Kay TWH; Thomas HE; O'Neal DN
    Diabet Med; 2021 Nov; 38(11):e14608. PubMed ID: 34043837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection.
    Jang KK; Kaczmarek ME; Dallari S; Chen YH; Tada T; Axelrad J; Landau NR; Stapleford KA; Cadwell K
    PLoS Biol; 2022 Mar; 20(3):e3001592. PubMed ID: 35358182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.